Abiopharma

🔍 Phelan Mark T. (Executive)

Company: Accel Entertainment, Inc. (ACEL)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 25,000 shares of Class A-1 Common Stock at $13.0 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 241,464.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The 10b5-1 plan included a representation from the Reporting Person to the broker administering the plan that the Reporting Person was not in possession of any material nonpublic information regarding the Issuer or the securities subject to the plan. That representation was made as of the date of the adoption of the 10b5-1 plan, and speaks only as of that date. In making that representation, there is no assurance with respect to any material nonpublic information of which the Reporting Person was unaware, or with respect to any material nonpublic information acquired by the Reporting Person after the date of the representation.